Wegovy Pill Philippines: The Oral Semaglutide Reality

Novo Nordisk sells the same molecule, semaglutide, under three brand names. Ozempic is the weekly injectable pen registered for diabetes. Wegovy is the weekly injectable pen registered for weight loss. Rybelsus is the once-daily tablet. When someone searches for a Wegovy pill or an Ozempic tablet, the product they are actually describing is Rybelsus.

A true oral Wegovy does exist in the pipeline: a 25mg oral semaglutide for obesity, along with the follow-up compound amycretin. Neither is marketed in the Philippines as of August 2026. If a Manila seller offers you a Wegovy pill today, you are looking at either mislabeled Rybelsus or a counterfeit.

For the injectable Wegovy pen itself, including pen-by-pen pesos, see my Wegovy price guide and the wider Ozempic price filing.

Rybelsus is a prescription medicine in the Philippines, dispensed the same way as the pens: a consult with a licensed Philippine physician first, then the script filled at a hospital pharmacy or a large retail branch. Stock is thinner than Ozempic stock, and the big Metro Manila branches are the ones worth calling, though even there the counter often has one dose strength but not the one on your script.

On price, there is nothing verified to publish. When we checked the major Philippine chains on 26 August 2026, none of them listed a peso price for Rybelsus: not Watsons, not Rose Pharmacy, not Southstar, not MedsGo. Mercury Drug publishes no medicine prices online at all. So the honest answer to "how much is Rybelsus in the Philippines" is that no mainstream pharmacy publishes a figure, and anyone quoting one is quoting a reseller or an import rather than a pharmacy listing. This page will not invent a range to fill that hole.

Worth knowing about the thin local presence: Novo Nordisk has retired the Rybelsus brand in the United States in favour of an oral Ozempic, so the tablet's commercial future sits with a different label. That is a plausible reason the Philippine shelf presence is patchy, and a reason to expect the naming to shift again.

For the pen-route baseline, which does have published figures: a Wegovy 2.4mg pen is ₱12,650 at Watsons and an Ozempic 1mg pen is ₱8,734 at Watsons, with MedsGo listing the same Ozempic pen at ₱7,850 on promotion. Each of those pens holds four weekly doses, so one pen is roughly one month. Checked 26 August 2026.

Compounded semaglutide is a term imported from the United States, where licensed 503A and 503B compounding pharmacies were allowed to produce semaglutide during the official FDA shortage. That shortage has been resolved and the US compounding window has largely closed.

The Philippines never had that channel. There is no FDA Philippines framework under which a local pharmacy legally compounds semaglutide. Anything marketed here as compounded semaglutide is, in practice, either a research-grade vial wearing a friendlier label or a grey import of a foreign compounded product with no local registration. Judge it by research-grade standards: third-party COA per batch, cold-chain shipping, and your own baseline labs, or walk away. Full legal picture in the Semaglutide Philippines 2026 guide.

The honest alternative to chasing a tablet that barely absorbs is the same one covered across this site: research-grade injectable semaglutide. A 5mg lyophilized vial with a verified third-party COA runs ₱2,800 to 4,500 (about $50 to 80) and covers a month or more at maintenance doses. Against ₱12,650 for a Wegovy 2.4mg pen at Watsons, that is roughly a three to four times gap rather than the five times this page used to claim, because the branded figure it was measured against was far too high. The molecule page has the full dosing and side-effect breakdown: semaglutide.

Research-grade compounds are not FDA Philippines-registered for human therapeutic use and are sold for laboratory research. Require a COA per batch and run your own labs.